Woodline Partners LP 4 D Molecular Therapeutics, Inc. Transaction History

Woodline Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.16 - $22.64 $1.74 Million - $2.99 Million	-132,117 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$19.56 - $32.94 $893,774 - $1.51 Million	45,694 Added 52.87%	132,117 $2.9 Million
Q3 2021 Nov 15, 2021	BUY	$22.73 - $36.04 $1.08 Million - $1.72 Million	47,715 Added 123.27%	86,423 $2.33 Million
Q2 2021 Aug 16, 2021	SELL	$22.2 - $42.29 $1.05 Million - $1.99 Million	-47,121 Reduced 54.9%	38,708 $932,000
Q1 2021 May 17, 2021	SELL	$35.94 - $52.67 $633,406 - $928,256	-17,624 Reduced 17.04%	85,829 $3.72 Million

Q4 2020 Feb 16, 2021	BUY	$38.43 - $47.36 $3.98 Million - $4.9 Million	103,453 New	103,453 $4.29 Million

157

50.3M

718K

370K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $675M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.